Melanoma Cellular Signaling Transduction Pathways Targeted by Polyphenols Action Mechanisms

Ecaterina Isacescu1, Paul Chiroi1, Oana Zanoaga1

  • 1Research Center for Functional Genomics, Biomedicine and Translational Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania.

Insights

Polyphenols, natural plant compounds, show promise in fighting melanoma. This review details how these compounds regulate key molecular mechanisms in melanoma cells, offering a basis for new treatments.

Area of Science:

  • Oncology
  • Pharmacology
  • Natural Products Chemistry

Background:

  • Melanoma remains a deadly skin cancer with limited treatment efficacy.
  • Polyphenols, natural compounds, exhibit significant anticancer properties.
  • A comprehensive review of polyphenol-mediated molecular mechanisms in melanoma is lacking.

Purpose of the Study:

  • To summarize the molecular mechanisms by which polyphenols affect melanoma initiation and progression.
  • To consolidate current knowledge on polyphenol interactions with essential cellular pathways in melanoma.
  • To highlight the role of polyphenols in regulating microRNAs (miRNAs) relevant to melanoma.

Main Methods:

  • Literature review of in vitro and in vivo studies on polyphenol effects in melanoma.
  • Analysis of polyphenol impact on cellular pathways: proliferation, apoptosis, autophagy, inflammation, angiogenesis, and metastasis.
  • Examination of polyphenol-mediated regulation of microRNAs (miRNAs) in melanoma.

Main Results:

  • Polyphenols modulate key cellular pathways crucial for melanoma development.
  • Evidence supports polyphenol efficacy in inhibiting melanoma cell proliferation and metastasis.
  • Polyphenols influence apoptosis, autophagy, inflammation, and angiogenesis in melanoma models.
  • Polyphenols regulate specific microRNAs (miRNAs) involved in melanoma pathogenesis.

Conclusions:

  • Polyphenols offer a promising therapeutic strategy for melanoma treatment.
  • Understanding polyphenol-regulated molecular mechanisms is vital for developing novel anti-melanoma agents.
  • This review provides a foundation for future research and clinical applications of polyphenols in melanoma therapy.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K